Hepatic stetaosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads
Jun-ping SHI,Jian-gao FAN,Guo-qiang LOU,Li ZHANG,Chen-bo HU,Rui WU,Yun-hao XUN
DOI: https://doi.org/10.3321/j.issn:1007-3418.2008.11.008
2008-01-01
Abstract:Objective To evaluate the causes of alanine aminotransferase (ALT) level elevation in HBsAg-positive chronic hepatitis B (CHB) patients with low HBV DNA loads. Methods One hundred nineteen HBsAg positive CHB patients with both serum HBV DNA loads < 103 copies/ml and ALT>1.25 upper limits of normal (ULN) lasting for at least 6 months were enrolled in this study. Patients co-infected with hepatitis C virus or HIV or suffering from other liver diseases were not included. HBV DNA loads were assayed by PCR. Serological biochemistry and liver biopsy histopathological changes and clinical character-istics of the patients were analyzed. Results Of the 119 patients 102 were males and 17 were females. The mean age of the patients was (33.9±9.7) years and their body mass index (BMI) was (23.4±3.7) kg/m2.Mean ALT levels were (150.0±166.6) U/L and AST levels were (102.4±193.2) U/L. Liver biopsies showed hepatic steatosis in 26.9 % (32/119) of the cases, chronic hepatitis in 53.8% (64/119), non-specific changes in 12.6% (15/119), and l without any change. However, hepatic steatosis was more frequently seen in patients taking nucleoside analogs (56.7%), χ2= 10.394, P < 0.01. BMI, apolipoprotein B (APO-B), triglyceride,cholesterol and uric acid were all significantly higher in patients with hepatic steatosis than those without (t values were 5.369, 4.276, 3.216, 4.223 and 2.438 respectively, all P < 0.05) while ALT, AST and apolipoprotein A were much lower in those with steatosis than those without (t values were -2.234, -3.877 and -2.956 respectively, all P < 0.05). Obesity, dyslipidemia and hyperuricemia were more frequently seen in patients with steatosis than in patients without it (χ2 value 3.829, 7.659, 13.389, 0.549, all P< 0.05). The severity of inflammation and fibrosis were also more significant in patients with steatosis (χ2 value 20.978, 17.550, all P < 0.05). As compared to those patients without specific changes, serum levels of ALT, AST, GGT in patients with chronic hepatitis were obviously higher, all P < 0.05. In contrast, there were no significant differences in mean age, BMI, male preference, obesity, diabates, dyslipidemia or hyperuricemia, and the levels of triglyceride,cholesterol, and fasting plasma glucose between the two groups. Conclusion Our data indicate that hepatic steatosis might be a factor associated with elevated ALT levels in HBsAg-positivc CHB patients with low HBV DNA loads, especially in patients treated with nucleoside analogs.